KEYNOTES

Dr. Clare Tempany, MD, is a professor of Radiology at Harvard Medical School. She is the Ferenc Jolesz Chair of Radiology Research at the Department of Radiology, Brigham & Women's Hospital and she is a diagnostic radiologist. She is the Principal Investigator of the P41 National Center of Image Guided Therapy (NCIGT) grant and the Medical Director of the Advanced Multimodal Image-Guided Operating (AMIGO) suite.

Dr. Tempany is an expert in Body MRI, specifically, Pelvic MRI. Her research interests include Pelvic Oncology, specifically, prostate cancer. She leads a large Prostate Research Program, which includes diagnostic, staging, and MR/US guided interventions (biopsy) and treatment guidance programs. Other interests are in image-guided therapy including computer-assisted technology development for multi-modal image display in the operating room.

Since 2000 she has been an active investigator in multiple trials of clinical MR-guided Focused Ultrasound Surgery (MRgFUS). She has completed three trials in the use of MRgFUS for treatment of uterine fibroids and an on-going trial for treatment of Metastatic bone tumors for palliation of pain. Using the device ExAblate 2000, the data resulted in FDA approval of the device in October 2004.

Kamil Ugurbil, Ph.D., is professor of Medicine, Neurosciences, and Radiology, and founding director of the Center for Magnetic Resonance Research (CMRR). He is one of the principal investigators of the Human Connectome Project (HCP), funded by US National Institutes of Health. Dr. Ugurbil is a pioneer in the arena of high-field MR development. He has extensive experience in leading major technology development efforts, including the world's first 7T scanner that provided preliminary data for the HCP grant. Within the CMRR, Dr. Ugurbil and his team have built a center with unique instrumentation and expertise that allows scientists to study Alzheimer's disease, schizophrenia, and other areas of brain science, as well as heart disease, cancer and metabolic disorders.

Dr. Yoav Medan, a social and technology entrepreneur, is currently a visiting scientist and an adjunct lecturer at the Technion Faculties of Electrical Engineering and Biomedical Engineering. Joining the Technion Faculty in 2012 after a lengthy career in industry as a visiting associate professor in Biomedical Engineering, Dr. Medan also teaches a course on entrepreneurship to engineering undergraduates, as part of a new minor degree track in Entrepreneurship. In addition, Dr. Medan is a mentor to entrepreneurs in the medical device field through the Technion for Life Alumni program, the Technion BizTec and MassChallenge programs. Prior to that Dr. Medan served as Vice President, Chief Systems Architect (1999- 2011) of InSightec Ltd, A medical device company pioneering non-invasive MR- Guided Focused Ultrasound surgery. From 1984 through 1998 Dr. Medan held various senior research and management positions at the IBM Haifa Research Laboratory. In 2013 Dr. Medan founded Haifa3D, a new non-profit open hub for 3D digital fabrication, hosted by the Tiltan College at the Haifa Port Campus. In 2014 he cofounded NiniSpeech Ltd., a startup company developing a real-time mobile biofeedback solution for people who stutter.